Pressure BioSciences, Inc. to Discuss First Quarter Financial Results and Provide Business Update

WEST BRIDGEWATER, Mass., May 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will file it's Quarterly Report on Form 10-QSB on Tuesday May 15, 2007 and will host a teleconference to discuss its first quarter 2007 financial results and to provide a business update on Wednesday May 16, 2007. The teleconference information provided below:

    Date: Wednesday, May 16, 2007
    Time: 4:30 p.m. Eastern time

    To attend this teleconference via web-cast go to:
    http://www.pressurebiosciences.com

    To attend this teleconference via telephone, dial:
    Dial-in: 800-922-2108
    Participant code: 5255404

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio- molecular interactions. PBI currently holds 13 U.S. and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended March 31, 2007, in the Company's Annual Report on Form 10-KSB, for the year ended December 31, 2006, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

SOURCE Pressure BioSciences, Inc.

Released May 14, 2007